Cargando…
The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies
| Autores principales: | , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432635/ https://www.ncbi.nlm.nih.gov/pubmed/34522844 http://dx.doi.org/10.1097/HS9.0000000000000642 |
| _version_ | 1783751204571971584 |
|---|---|
| author | Einsele, Hermann Briones, Javier Ciceri, Fabio García Cadenas, Irene Falkenburg, Fred Bolaños, Natacha Heemskerk, H.M. Mirjam Houot, Roch Hudecek, Michael Locatelli, Franco Morgan, Kate Morris, Emma C. O’Dwyer, Michael Sierra, Jordi Gil van den Brink, Marcel van de Loosdrecht, Arjan A. |
| author_facet | Einsele, Hermann Briones, Javier Ciceri, Fabio García Cadenas, Irene Falkenburg, Fred Bolaños, Natacha Heemskerk, H.M. Mirjam Houot, Roch Hudecek, Michael Locatelli, Franco Morgan, Kate Morris, Emma C. O’Dwyer, Michael Sierra, Jordi Gil van den Brink, Marcel van de Loosdrecht, Arjan A. |
| author_sort | Einsele, Hermann |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8432635 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84326352021-09-13 The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies Einsele, Hermann Briones, Javier Ciceri, Fabio García Cadenas, Irene Falkenburg, Fred Bolaños, Natacha Heemskerk, H.M. Mirjam Houot, Roch Hudecek, Michael Locatelli, Franco Morgan, Kate Morris, Emma C. O’Dwyer, Michael Sierra, Jordi Gil van den Brink, Marcel van de Loosdrecht, Arjan A. Hemasphere Perspective Lippincott Williams & Wilkins 2021-09-10 /pmc/articles/PMC8432635/ /pubmed/34522844 http://dx.doi.org/10.1097/HS9.0000000000000642 Text en Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
| spellingShingle | Perspective Einsele, Hermann Briones, Javier Ciceri, Fabio García Cadenas, Irene Falkenburg, Fred Bolaños, Natacha Heemskerk, H.M. Mirjam Houot, Roch Hudecek, Michael Locatelli, Franco Morgan, Kate Morris, Emma C. O’Dwyer, Michael Sierra, Jordi Gil van den Brink, Marcel van de Loosdrecht, Arjan A. The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title_full | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title_fullStr | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title_full_unstemmed | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title_short | The EHA Research Roadmap: Immune-based Therapies for Hematological Malignancies |
| title_sort | eha research roadmap: immune-based therapies for hematological malignancies |
| topic | Perspective |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432635/ https://www.ncbi.nlm.nih.gov/pubmed/34522844 http://dx.doi.org/10.1097/HS9.0000000000000642 |
| work_keys_str_mv | AT einselehermann theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT brionesjavier theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT cicerifabio theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT garciacadenasirene theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT falkenburgfred theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT bolanosnatacha theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT heemskerkhmmirjam theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT houotroch theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT hudecekmichael theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT locatellifranco theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT morgankate theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT morrisemmac theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT odwyermichael theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT sierrajordigil theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT vandenbrinkmarcel theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT vandeloosdrechtarjana theeharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT einselehermann eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT brionesjavier eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT cicerifabio eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT garciacadenasirene eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT falkenburgfred eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT bolanosnatacha eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT heemskerkhmmirjam eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT houotroch eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT hudecekmichael eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT locatellifranco eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT morgankate eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT morrisemmac eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT odwyermichael eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT sierrajordigil eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT vandenbrinkmarcel eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies AT vandeloosdrechtarjana eharesearchroadmapimmunebasedtherapiesforhematologicalmalignancies |